Related Experiment Video
Updated: Jul 7, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
[Seroma after axillary lymph node dissection in breast cancer]
N Douay1, G Akerman1, D Clément1
1Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
Sentinel node biopsy and axillary padding help reduce seroma complications after breast cancer surgery. Further research is needed for a definitive consensus on preventing lymphocele post-axillary dissection.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Management
Context:
- Axillary lymph node dissection remains a reference treatment for certain breast cancers.
- Seroma formation is a frequent postoperative complication, irrespective of surgical technique.
- Sentinel node biopsy has reduced axillary surgery morbidity.
Purpose:
- To review literature on risk factors and preventative techniques for seroma formation after axillary dissection in breast cancer.
- To identify effective strategies for reducing seroma incidence and volume.
Summary:
- Risk factors for seroma include high BMI, high initial drainage volume, and hypertension.
- Sentinel node biopsy, axillary padding, and axillary drainage show potential benefits in reducing seroma.
- Many other techniques yield contradictory results, lacking clinical recommendation.
Impact:
- Highlights sentinel node biopsy and axillary padding as currently distinguished techniques for seroma reduction.
- Emphasizes the lack of established consensus for managing postoperative seroma after breast cancer axillary dissection.
- Informs clinical practice regarding potential strategies to mitigate seroma complications.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025